Target intelligence / Profile preview

Small ribosomal subunit A-site (protozoan-like) (30S A-site)

Target
30S A-site
Molecular classification
Ribonucleoprotein, Ribosomal RNA
01

Overview

The 30S ribosomal subunit A-site in protozoan-like ribosomes refers to the decoding region of the small ribosomal subunit in certain protozoan parasites that exhibits structural similarities to bacterial ribosomes (Vicens & Westhof, 2001, PMID: 11511172). This site, located within the 16S-like (or 18S) ribosomal RNA, is responsible for ensuring the fidelity of translation by monitoring the base-pairing between the mRNA codon and the aminoacyl-tRNA anticodon (Carter et al., 2000, PMID: 11007470). In many protozoa, such as Leishmania and Entamoeba, the A-site contains specific nucleotide sequences that render it highly sensitive to aminoglycoside antibiotics, which typically target prokaryotic 30S subunits (Fong et al., 1994, PMID: 7979288). Drugs like paromomycin bind specifically to this A-site, stabilizing the flipped-out conformation of conserved adenine residues, which forces the ribosome to accept near-cognate tRNAs (Shalev et al., 2002, PMID: 12140348). This interaction leads to the synthesis of dysfunctional proteins and eventual parasite cell death. Because human cytosolic 40S ribosomes possess structural differences at this site, these drugs can achieve selective toxicity, although potential cross-reactivity with human mitochondrial ribosomes remains a therapeutic challenge (Hobbie et al., 2007, PMID: 17617542).

Other names
Decoding siteA-site of the 16S-like rRNAAminoglycoside binding site18S rRNA A-site (protozoan)Apicoplast 30S ribosomal A-site
02

Mechanism of action

Binding to the decoding A-site of the small ribosomal subunit, inducing conformational changes that lead to mistranslation and inhibition of protein synthesis.

03

Biological functions

Protein synthesisTranslationmRNA decoding
04

Disease associations

InfectionLeishmaniasisAmoebiasisGiardiasisCryptosporidiosis
05

Safety considerations

OtotoxicityNephrotoxicityNeuromuscular blockadePoor oral bioavailabilityPotential cross-reactivity with human mitochondrial ribosomes
06

Interacting drugs

Paromomycin

3 more in the full profile.

07

Biomarkers

rRNA sequence polymorphisms16S-like rRNA mutations (e.g., A1408G equivalent)

Beyond the preview

Go deeper on Small ribosomal subunit A-site (protozoan-like) (30S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small ribosomal subunit A-site (protozoan-like) (30S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call